Agentix Corp. (OTCPK: AGTX)
Health Care · Biotechnology · US
$0.02
— today · -59.9% 1Y
Agentix Corp. (OTCPK: AGTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $801.34K and employs 2 people.
Over the last twelve months the share price has lost 59.9%, trading between 0.01 and 0.06.
Tweenvest scores Agentix Corp. across four factors: quality 13/100, value 50/100. Its strongest factor is value.
AGTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $801.34K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.08
- 52-week high
- $0.06
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 40.07M
- Employees
- 2
- Next earnings
- —
About Agentix Corp.
Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
- ISIN
- US00848A1034
- Founded
- 2020
- Listed since
- Aug 21, 2015
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sunshine Biopharma, Inc.NasdaqCM: SBFM | $859.99K | $0.22 | -34.34% |
| Epigenomics AGDB: ECX | $858.33K | €0.87 | -1.14% |
| Silexion Therapeutics CorpNasdaqCM: SLXN | $850.72K | $0.15 | -28.70% |
| Alligator Bioscience AB (publ)OM: ATORX | $837.19K | Skr0.01 | -13.73% |
| Hindustan Bio Sciences LimitedBSE: 532041 | $766.86K | Rs7.10 | -4.70% |
| Decoy Therapeutics Inc.NasdaqCM: DCOY | $766.57K | $1.17 | -20.41% |
| Helix BioMedix, Inc.OTCPK: HXBM | $739.29K | $— | — |
| Smart Agro - LimitedTASE: SMAG | $731.90K | ₪0.54 | -1.29% |
Figures last refreshed Oct 18, 2026.